14 Years Manufacturer Soybean extract Supply to Greece
14 Years Manufacturer Soybean extract Supply to Greece Detail:
[Latin Name] Glycine max (L.) Mere
[Plant Source] China
[Specifications] Isoflavones 20%, 40%, 60%
[Appearance] Brown yellow fine powder
[Plant Part Used] Soybean
[Particle size] 80 Mesh
[Loss on drying] ≤5.0%
[Heavy Metal] ≤10PPM
[Storage] Store in cool & dry area, keep away from the direct light and heat.
[Package] Packed in paper-drums and two plastic-bags inside.
[Active ingredients]
[What is Soy Isoflavones]
Non-genetically modified soybean refined soy isoflavones, a natural nutritional factors for a variety of important physiological activity is a natural plant estrogen, easily absorbed by the body.
Isoflavones are phytoestrogens planned economy a weak hormones, soy is the only valid source of human access to isoflavones. In the case of strong estrogen physiological activity, isoflavones can play the role of anti-estrogen. Isoflavones very prominent anti-cancer properties, can hinder the growth and spread of cancer cells and only cancer, isoflavones had no impact on normal cells. Isoflavones has an effective of anti-oxidant.
[Functions]
1. Lower Cancer Risk In Men and Women;
2. Use In Estrogen Replacement Therapy;
3. Lower Cholesterol and Reduce Heart Disease Risk;
4. Relieve women menopause syndrome, guard against osteoporosis;
5. Protect human body from destroy by free-radical to advance immunity;
6. Be healthy for stomach and spleen and protect nerve system;
7. Reduce cholesterin thickness in human body, prevent and cure cardiovascular disease;
8. Prevent cancer and counteract cancer£¬for example, prostate cancer, breast cancer.
[Application] Used in Lower cancer risk, estrogen replacement therapy, advance immunity, prevent and cure cardiovascular disease.
Product detail pictures:

Related Product Guide:
continue on to further improve, to make sure product top quality in line with market and consumer standard requirements. Our firm has a excellent assurance program have already been established for 14 Years Manufacturer Soybean extract Supply to Greece , The product will supply to all over the world, such as: Las Vegas, Portland, Australia, Ought to any of these products be of curiosity to you, remember to allow us to know. We are going to be satisfied to give you a quotation on receipt of one's in depth specs. We've our private experienced R&D enginners to meet any of one's requriements, We appear forward to receiving your enquires soon'and hope to have the opportunity to work together with you in the future. Welcome to check out our company.
We take some grape seeds and set up a scarification treatment experiment. Watch the follow up to see results and some more techniques
“Equine Polysaccharide Storage Myopathy” is an inheritable glycogen storage disease of horses that causes exertional rhabdomyolysis. It is most commonly associated with heavy horse breeds and the American Quarter Horse. While incurable, PSSM can be managed with appropriate diet and exercise. There are currently 2 subtypes, known as Type 1 PSSM and Type 2 PSSM.
Glycogen is a molecular polymer of glucose used to store energy, and is important for maintaining glucose hemostasis in the blood, as well as for providing energy for skeletal muscle and cardiac muscle contraction. Molecules of glucose are linked into linear chains by α-1,4-glycosidic bonds. Additionally, branches of glucose are formed off of the chain by α-1,6-glycosidic bonds. 2 molecules of glucose are joined into an α-1,4-glycosidic bonds by an enzyme known as glycogen synthase. This bond may be broken by amylase when the body wishes to break down glycogen into glucose for energy. Glycogen branching enzyme is responsible for the required α-1,6-glycosidic bonds needed to start a branch off of these linear chains.
Any disruption to this system results in a glycogen storage disease. There are currently 3 subcategories of glycogen storage diseases in horses: Type 1 Polysaccharide Storage Myopathy, Glycogen Branching Enzyme Deficiency , and Type 2 Polysaccharide Storage Myopathy.
Type 1 PSSM is caused by an autosomal dominant genetic mutation known as GSY1. This mutation causes an up-regulation of glycogen synthase, and high levels of glycogen synthase relative to glycogen branching enzyme . This altered ratio of glycogen synthase to GBE results in glycogen molecules with long chains and few branches, making these molecules somewhat amylase resistant. The GSY1 mutation is associated with altered glucose metabolism , as well as accumulation of high levels of glycogen and abnormal polysaccharide in the muscles of the horse. Additionally, some horses have been shown to have insulin sensitivity, which improves glucose uptake by muscle cells and contributes to excessive glycogen storage that is already elevated secondary to the GSY1 mutation.
Wiz Science™ is “the” learning channel for children and all ages.
SUBSCRIBE TODAY
Disclaimer: This video is for your information only. The author or publisher does not guarantee the accuracy of the content presented in this video. USE AT YOUR OWN RISK.
Background Music:
“The Place Inside” by Silent Partner (royalty-free) from YouTube Audio Library.
This video uses material/images from https://en.wikipedia.org/wiki/Equine+polysaccharide+storage+myopathy, which is released under Creative Commons Attribution-Share-Alike License 3.0 https://creativecommons.org/licenses/by-sa/3.0/ . This video is licensed under Creative Commons Attribution-Share-Alike License 3.0 https://creativecommons.org/licenses/by-sa/3.0/ . To reuse/adapt the content in your own work, you must comply with the license terms.

The sales manager is very patient, we communicated about three days before we decided to cooperate, finally, we are very satisfied with this cooperation!
